Emily S. Tonorezos, MD, on Childhood Cancer Survivors and Late-Occurring Effects
2017 Cancer Survivorship SymposiumEmily S. Tonorezos, MD, of Memorial Sloan Kettering Cancer Center, discusses childhood cancer survivors and the protection from late-occurring anthracycline-related cardiotoxicity conferred by a RARG coding variant.
Related Videos
Shoshana M. Rosenberg, ScD, MPH, on Young Breast Cancer Survivors: Helping Them Cope
Shoshana M. Rosenberg, ScD, MPH, of the Dana-Farber Cancer Institute, talks about ways to help young women move from active treatment to survivorship, based on findings from focus gro...
Arti Hurria, MD, on Senior Citizens: Living Through and Beyond Cancer
Arti Hurria, MD, of City of Hope, discusses the assessment of older patients with cancer.
Electra D. Paskett, PhD, on Preventing Lymphedema: Results of a CALGB Study
Electra D. Paskett, PhD, of The Ohio State University Comprehensive Cancer Center, discusses an intervention that increased knowledge of lymphedema in breast cancer, and the personal ...
Allison Harvey, MPH, CHES, on Teaching Providers About Survivorship
Allison Harvey, MPH, CHES, of George Washington University, evaluates preliminary outcomes among primary care and oncology providers who took part in the Cancer Survivorship E-Learning Series (Abstrac...
Shawna V. Hudson, PhD, on Breast Cancer: A Quality-of-Life Program
Shawna V. Hudson, PhD, of Rutgers University, discusses a survivorship program designed to improve the quality of life for Hispanic and Latino breast cancer survivors (Abstract 183).
